13min chapter

The Dr. Tyna Show cover image

GLP-1 Agonists and the Gut Microbiome: Unveiling Their Role in Metabolic Health | Solo Episode

The Dr. Tyna Show

CHAPTER

Exploring the Impact of GLP-1 Agonists on Gut Microbiome and Metabolic Health

This chapter explores the effects of GLP-1 agonist dulaclutide on the gut microbiome in type 2 diabetes patients. It highlights research showing how long-term use can modify intestinal flora, linking these changes to improved metabolic health markers.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode